{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:11:16Z","timestamp":1792725076618,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11926-019-0845-6","type":"journal-article","created":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T23:45:06Z","timestamp":1563147906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis"],"prefix":"10.1007","volume":"21","author":[{"given":"Marialbert","family":"Acosta-Herrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"L\u00f3pez-Isac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"issue":"19","key":"845_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989\u20132003.","journal-title":"N Engl J Med"},{"key":"845_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","volume":"6","author":"TR Katsumoto","year":"2011","unstructured":"Katsumoto TR, Whitfield ML, Connolly MK. The pathogenesis of systemic sclerosis. Annu Rev Pathol. 2011;6:509\u201337.","journal-title":"Annu Rev Pathol"},{"issue":"10103","key":"845_CR3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390(10103):1685\u201399.","journal-title":"Lancet"},{"issue":"6","key":"845_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001;44(6):1359\u201362.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"845_CR5","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA Jr, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48(7):1956\u201363.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"845_CR6","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1002\/art.22647","volume":"56","author":"S Assassi","year":"2007","unstructured":"Assassi S, Arnett FC, Reveille JD, Gourh P, Mayes MD. Clinical, immunologic, and genetic features of familial systemic sclerosis. Arthritis Rheum. 2007;56(6):2031\u20137.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"845_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189498","volume":"13","author":"OY Gorlova","year":"2018","unstructured":"Gorlova OY, Li Y, Gorlov I, Ying J, Chen WV, Assassi S, et al. Gene-level association analysis of systemic sclerosis: a comparison of African-Americans and White populations. PLoS One. 2018;13(1):e0189498.","journal-title":"PLoS One"},{"key":"845_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","volume":"64","author":"L Bossini-Castillo","year":"2015","unstructured":"Bossini-Castillo L, Lopez-Isac E, Martin J. Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways. J Autoimmun. 2015;64:53\u201365.","journal-title":"J Autoimmun"},{"issue":"7","key":"845_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrrheum.2017.80","volume":"13","author":"S Eyre","year":"2017","unstructured":"Eyre S, Orozco G, Worthington J. The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping. Nat Rev Rheumatol. 2017;13(7):421\u201332.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"845_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/ar3204","volume":"13","author":"A Cortes","year":"2011","unstructured":"Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther. 2011;13(1):101.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"845_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856\u201360.","journal-title":"Nat Genet"},{"issue":"5","key":"845_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TR Radstake","year":"2010","unstructured":"Radstake TR, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet. 2010;42(5):426\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"845_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1136\/ard.2010.147009","volume":"70","author":"P Dieude","year":"2011","unstructured":"Dieude P, Boileau C, Guedj M, Avouac J, Ruiz B, Hachulla E, et al. Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor. Ann Rheum Dis. 2011;70(9):1695\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"845_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002091","volume":"7","author":"Y Allanore","year":"2011","unstructured":"Allanore Y, Saad M, Dieud\u00e9 P, Avouac J, Distler JHW, Amouyel P, et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet. 2011;7(7):e1002091.","journal-title":"PLoS Genet"},{"issue":"4","key":"845_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/annrheumdis-2012-201888","volume":"72","author":"L Bossini-Castillo","year":"2013","unstructured":"Bossini-Castillo L, Martin JE, Broen J, Simeon CP, Beretta L, Gorlova OY, et al. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Ann Rheum Dis. 2013;72(4):602\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"845_CR16","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/art.24982","volume":"60","author":"X Zhou","year":"2009","unstructured":"Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum. 2009;60(12):3807\u201314.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"845_CR17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/hmg\/ddr522","volume":"21","author":"L Bossini-Castillo","year":"2012","unstructured":"Bossini-Castillo L, Martin JE, Broen J, Gorlova O, Sime\u00f3n CP, Beretta L, et al. A GWAS follow-up study reveals the association of the IL1e2RB2 gene with systemic sclerosis in Caucasian populations. Hum Mol Genet. 2012;21(4):926\u201333.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"845_CR18","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/hmg\/dds099","volume":"21","author":"JE Martin","year":"2012","unstructured":"Martin JE, Broen JC, Carmona FD, Teruel M, Simeon CP, Vonk MC, et al. Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up. Hum Mol Genet. 2012;21(12):2825\u201335.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"845_CR19","doi-asserted-by":"publisher","first-page":"R6","DOI":"10.1186\/ar4432","volume":"16","author":"E Lopez-Isac","year":"2014","unstructured":"Lopez-Isac E, et al. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility. Arthritis Res Ther. 2014;16(1):R6.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"845_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","volume":"94","author":"MD Mayes","year":"2014","unstructured":"Mayes MD, Bossini-Castillo L, Gorlova O, Martin JE, Zhou X, Chen WV, et al. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. Am J Hum Genet. 2014;94(1):47\u201361.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"845_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","volume":"16","author":"J Zochling","year":"2014","unstructured":"Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A, et al. An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Res Ther. 2014;16(5):438.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"845_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11065-016-9319-z","volume":"26","author":"MW Cheung","year":"2016","unstructured":"Cheung MW, Vijayakumar R. A guide to conducting a meta-analysis. Neuropsychol Rev. 2016;26(2):121\u20138.","journal-title":"Neuropsychol Rev"},{"key":"845_CR23","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Genetics for all. Nat Genet, 2019. 51(4): p. 579. This editorial shows how most of the genetic studies haven been carried out in European populations and how this will bias their impact on health in genetically diverse populations.","DOI":"10.1038\/s41588-019-0394-y"},{"issue":"6","key":"845_CR24","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","volume":"76","author":"C Terao","year":"2017","unstructured":"\u2022 Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, et al. Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis. Ann Rheum Dis. 2017;76(6):1150\u20138 This study represents the first transethinic meta-analysis in SSc among European and Asian population, highlighting the potential of studying other populations to find new genetic risk factors in complex diseases.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"845_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/rheumatology\/key281","volume":"58","author":"D Gonzalez-Serna","year":"2019","unstructured":"\u2022 Gonzalez-Serna D, et al. Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study. Rheumatology (Oxford). 2019;58(2):289\u201398 This paper confirms the association of the classical allele HLA-DRB1*11:04 with SSc in several populations.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"845_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002178","volume":"7","author":"O Gorlova","year":"2011","unstructured":"Gorlova O, Martin JE, Rueda B, Koeleman BPC, Ying J, Teruel M, et al. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet. 2011;7(7):e1002178.","journal-title":"PLoS Genet"},{"issue":"12","key":"845_CR27","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3899\/jrheum.090377","volume":"36","author":"CP Simeon","year":"2009","unstructured":"Simeon CP, et al. Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol. 2009;36(12):2733\u20136.","journal-title":"J Rheumatol"},{"issue":"5","key":"845_CR28","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/ard.2009.111906","volume":"69","author":"FC Arnett","year":"2010","unstructured":"Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK, et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis. 2010;69(5):822\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"845_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/ker335","volume":"51","author":"L Beretta","year":"2012","unstructured":"Beretta L, Rueda B, Marchini M, Santaniello A, Simeon CP, Fonollosa V, et al. Analysis of class II human leucocyte antigens in Italian and Spanish systemic sclerosis. Rheumatology (Oxford). 2012;51(1):52\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"845_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126727","volume":"10","author":"TS Rodriguez-Reyna","year":"2015","unstructured":"Rodriguez-Reyna TS, Mercado-Vel\u00e1zquez P, Yu N, Alosco S, Ohashi M, Lebedeva T, et al. HLA class I and II blocks are associated to susceptibility, clinical subtypes and autoantibodies in Mexican systemic sclerosis (SSc) patients. PLoS One. 2015;10(5):e0126727.","journal-title":"PLoS One"},{"issue":"9","key":"845_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrg3502","volume":"14","author":"M Parkes","year":"2013","unstructured":"Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet. 2013;14(9):661\u201373.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"845_CR32","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2013.161","volume":"9","author":"A Zhernakova","year":"2013","unstructured":"Zhernakova A, Withoff S, Wijmenga C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol. 2013;9(11):646\u201359.","journal-title":"Nat Rev Endocrinol"},{"issue":"19","key":"845_CR33","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","volume":"22","author":"JE Martin","year":"2013","unstructured":"Martin JE, Assassi S, Diaz-Gallo LM, Broen JC, Simeon CP, Castellvi I, et al. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Hum Mol Genet. 2013;22(19):4021\u20139.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"845_CR34","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.39730","volume":"68","author":"E Lopez-Isac","year":"2016","unstructured":"Lopez-Isac E, et al. Brief report: IRF4 newly identified as a common susceptibility locus for systemic sclerosis and rheumatoid arthritis in a cross-disease meta-analysis of genome-wide association studies. Arthritis Rheumatol. 2016;68(9):2338\u201344.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"845_CR35","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.3933","volume":"21","author":"YR Li","year":"2015","unstructured":"Li YR, Li J, Zhao SD, Bradfield JP, Mentch FD, Maggadottir SM, et al. Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases. Nat Med. 2015;21(9):1018\u201327.","journal-title":"Nat Med"},{"issue":"5","key":"845_CR36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ng.3528","volume":"48","author":"D Ellinghaus","year":"2016","unstructured":"Ellinghaus D, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510\u20138.","journal-title":"Nat Genet"},{"issue":"1","key":"845_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13073-018-0604-8","volume":"10","author":"A Marquez","year":"2018","unstructured":"\u2022\u2022 Marquez A, et al. Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations. Genome Med. 2018;10(1):97 This study shows the common genetic architecture of SSc with other autoimmune diseases and its potential on drug repositioning.","journal-title":"Genome Med"},{"issue":"3","key":"845_CR38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2018-214127","volume":"78","author":"M Acosta-Herrera","year":"2019","unstructured":"\u2022\u2022 Acosta-Herrera M, et al. Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases. Ann Rheum Dis. 2019;78(3):311\u20139 This paper identifies shared genetics across systemic seropositive rheumatic diseases with functional value and significantly enriched in drug targets, calling our attention on their potential for drug repurposing.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"845_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41584-018-0099-0","volume":"14","author":"C Angiolilli","year":"2018","unstructured":"\u2022\u2022 Angiolilli C, et al. New insights into the genetics and epigenetics of systemic sclerosis. Nat Rev Rheumatol. 2018;14(11):657\u201373 This review shows how different epigenetic studies in SSc might impact on the treatment of the disease.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"845_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/annrheumdis-2018-214295","volume":"78","author":"M van der Kroef","year":"2019","unstructured":"\u2022 van der Kroef M, et al. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting. Ann Rheum Dis. 2019;78(4):529\u201338 This study is an example of how epigenetic modifications can be targeted for the development of new therapies in SSc.","journal-title":"Ann Rheum Dis"},{"issue":"7539","key":"845_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"C Roadmap Epigenomics","year":"2015","unstructured":"Roadmap Epigenomics C, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317\u201330.","journal-title":"Nature"},{"issue":"2","key":"845_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.gde.2010.02.002","volume":"20","author":"S Schoenfelder","year":"2010","unstructured":"Schoenfelder S, Clay I, Fraser P. The transcriptional interactome: gene expression in 3D. Curr Opin Genet Dev. 2010;20(2):127\u201333.","journal-title":"Curr Opin Genet Dev"},{"issue":"6","key":"845_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10069","volume":"6","author":"P Martin","year":"2015","unstructured":"Martin P, McGovern A, Orozco G, Duffus K, Yarwood A, Schoenfelder S, et al. Capture Hi-C reveals novel candidate genes and complex long-range interactions with related autoimmune risk loci. Nat Commun. 2015;6(6):10069.","journal-title":"Nat Commun"},{"key":"845_CR44","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Schoenfelder, S., et al., Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet, 2019. In press. This review goes over the enhancer-promoter interactions in the genome and their impact on development and disease.","DOI":"10.1038\/s41576-019-0128-0"},{"key":"845_CR45","doi-asserted-by":"crossref","unstructured":"\u2022 Martin, P., et al., Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseases. Ann Rheum Dis, 2019. In press. This paper is an example of how functional genomics is an effective tool to identify new treatments and drug repurposing in related diseases.","DOI":"10.1136\/annrheumdis-2018-214649"},{"issue":"1","key":"845_CR46","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13059-016-1078-x","volume":"17","author":"A McGovern","year":"2016","unstructured":"McGovern A, et al. Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23. Genome Biol. 2016;17(1):212.","journal-title":"Genome Biol"},{"issue":"9","key":"845_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"\u2022\u2022 Torkamani A, et al. The personal and clinical utility of polygenic risk scores. Nat Rev Genet. 2018;19(9):581\u201390 This study reviews the clinical utility of polygenic risk scores.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"845_CR48","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41591-018-0231-3","volume":"24","author":"GWAS to the people","year":"2018","unstructured":"GWAS to the people. Nat Med. 2018;24(10):1483.","journal-title":"Nat Med"},{"issue":"9","key":"845_CR49","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41588-018-0213-x","volume":"50","author":"AJ Schork","year":"2018","unstructured":"Schork AJ, Schork MA, Schork NJ. Genetic risks and clinical rewards. Nat Genet. 2018;50(9):1210\u20131.","journal-title":"Nat Genet"},{"issue":"25","key":"845_CR50","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMp1904511","volume":"380","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Drazen JM. Has the genome granted our wish yet? N Engl J Med. 2019;380(25):2391\u20133.","journal-title":"N Engl J Med"},{"issue":"9","key":"845_CR51","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"\u2022 Khera AV, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50(9):1219\u201324 This paper highlights the impact of stratifying patients at risk based on polygenic risk scores to enable early disease detection and intervention. The authors discuss how genetic prediction should be included into medical care.","journal-title":"Nat Genet"}],"updated-by":[{"DOI":"10.1007\/s11926-019-0849-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T00:00:00Z","timestamp":1565740800000}}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-019-0845-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:16:09Z","timestamp":1594667769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-019-0845-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["845"],"URL":"https:\/\/doi.org\/10.1007\/s11926-019-0845-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"15 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained a mistake. The legend of Fig.\u00a01 was incorrect.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"44"}}